← back to search

Xiaohong Liu

Guangzhou University of Chinese Medicine · CN
Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Medicine, Biology, Gene, Meta-analysis, COPD, and Pulmonary disease.
h-index
citations
194
works
20
NIH funding
primary concept
email

Recent publications

Pan-cancer identified ARPC1B as a promising target for tumor immunotherapy and prognostic biomarker, particularly in READ
Heliyon 2024cited by 2position: middledoi
Novel Insights into Causal Effects of Serum Lipids and Apolipoproteins on Cardiovascular Morpho-Functional Phenotypes
Cardiovascular Toxicology 2024cited by 2position: middledoi
Correction: Novel Insights into Causal Effects of Serum Lipids and Apolipoproteins on Cardiovascular Morpho-Functional Phenotypes
Cardiovascular Toxicology 2024cited by 1position: middledoi
Correction to: Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways
Applied Biochemistry and Biotechnology 2024cited by 0position: lastdoi
Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways
Applied Biochemistry and Biotechnology 2023cited by 10position: lastdoi
Effects of traditional mind–body movement therapy on chronic cardiopulmonary dyspnoea: a systematic review and meta-analysis
Thorax 2022cited by 12position: middledoi
Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis
Life Sciences 2021cited by 19position: middledoi
Identification of Potential Pathogenic Super-Enhancers-Driven Genes in Pulmonary Fibrosis
Frontiers in Genetics 2021cited by 9position: middledoi
Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19
Frontiers in Pharmacology 2021cited by 7position: middledoi
Src family kinases and pulmonary fibrosis: A review
Biomedicine & Pharmacotherapy 2020cited by 79position: middledoi
Tracheal development after left pulmonary artery reimplantation: an individual study
Scientific Reports 2020cited by 4position: middledoi
Efficacy and safety of Chuankezhi injection in patients with chronic obstructive pulmonary disease
Medicine 2020cited by 2position: middledoi
A Network Pharmacology-based Analysis of the Molecular Mechanism of Tanreqing in the Treatment of the Coronavirus Disease 2019 (COVID-19)
2020cited by 2position: middledoi
Role of Aqueous Extract of the Wood Ear Mushroom, Auricularia polytricha (Agaricomycetes), in Avoidance of Haloperidol-lnduced Catalepsy via Oxidative Stress in Rats
International journal of medicinal mushrooms 2019cited by 21position: firstdoi
Network pharmacology—Deciphering the molecular mechanism of San-Zi-Yang-Qin decoction for the treatment of chronic obstructive pulmonary disease
European Journal of Integrative Medicine 2019cited by 7position: lastdoi
Efficacy and safety of acupoint autohemotherapy in treating stable chronic obstructive pulmonary disease
Medicine 2019cited by 5position: lastdoi
Traditional Chinese exercise (TCE) on pulmonary rehabilitation in patients with stable chronic obstructive pulmonary disease
Medicine 2019cited by 4position: lastdoi
[Systematically review of modified Sanzi Yangqin Decoction for treating acute exacerbation of chronic obstructive pulmonary disease].
PubMed 2019cited by 4position: lastdoi
Thirteen kinds of Chinese medicine injections for acute exacerbation of chronic obstructive pulmonary disease
Medicine 2019cited by 2position: lastdoi
[Meta-analysis and trial sequential analysis of modified Sangbaipi Decoction for treating acute exacerbation of chronic obstructive pulmonary disease].
PubMed 2019cited by 2position: lastdoi
Mortality and Morbidity of Extremely Low Birth Weight Infants in the Mainland of China
Chinese Medical Journal 2015cited by 49position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wenjiang Zheng · Guangzhou University of Chinese Medicine8 papers (2019–2021)Hui-Ting Huang · Guangzhou University of Chinese Medicine6 papers (2019–2022)Qian Yan · Guangzhou University of Chinese Medicine6 papers (2019–2021)Tiange Zhang · Guangzhou University of Chinese Medicine4 papers (2019–2022)Hong Yu · Harbin Medical University4 papers (2019–2019)Zijing Peng · Guangzhou University of Chinese Medicine4 papers (2019–2019)Huili Liao · Guangzhou University of Chinese Medicine3 papers (2019–2019)Caiping Zhao · Guangzhou University of Chinese Medicine2 papers (2020–2021)Yuanhao Wei · Harbin Medical University2 papers (2024–2024)Zhanhua Li · Guangxi Medical University2 papers (2023–2024) · 2 papers (2024–2024) · 2 papers (2023–2024)Shaofeng Zhan · Guangzhou University of Chinese Medicine2 papers (2021–2021)Chaoyuan Zhang · Guangzhou University of Chinese Medicine2 papers (2019–2020)Meiling Zhu · Guangzhou University of Chinese Medicine2 papers (2020–2021) · 2 papers (2024–2024) · 2 papers (2024–2024)Yi Chen · South China Agricultural University2 papers (2024–2024)Hang Li · Guangzhou University of Chinese Medicine2 papers (2020–2021)Haoyang Zhang · Zhengzhou University of Light Industry2 papers (2023–2024)